Topical Brimonidine Tartrate 0.33% Gel on Postlaser Erythema: Our Experience and Review of the Literature

Dermatol Surg. 2018 Jan;44(1):144-147. doi: 10.1097/DSS.0000000000001389.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Brimonidine Tartrate / administration & dosage*
  • Erythema / drug therapy*
  • Erythema / etiology
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / etiology
  • Female
  • Gels
  • Humans
  • Laser Therapy / adverse effects*
  • Male
  • Middle Aged
  • Vasoconstrictor Agents / administration & dosage*
  • Young Adult

Substances

  • Gels
  • Vasoconstrictor Agents
  • Brimonidine Tartrate